Your browser doesn't support javascript.
loading
Proteomics analysis of the p.G849D variant in neurexin 2 alpha may reveal insight into Parkinson's disease pathobiology.
Cuttler, Katelyn; Fortuin, Suereta; Müller-Nedebock, Amica Corda; Vlok, Maré; Cloete, Ruben; Bardien, Soraya.
Affiliation
  • Cuttler K; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Fortuin S; Faculty of Medicine and Health Sciences, African Microbiome Institute, Stellenbosch University, Cape Town, South Africa.
  • Müller-Nedebock AC; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Vlok M; South African Medical Research Council/Stellenbosch University Genomics of Brain Disorders Research Unit, Cape Town, South Africa.
  • Cloete R; Mass Spectrometry Unit, Central Analytical Facilities, Stellenbosch University, Cape Town, South Africa.
  • Bardien S; South African Medical Research Council Bioinformatics Unit, South African National Bioinformatics Institute, University of the Western Cape, Cape Town, South Africa.
Front Aging Neurosci ; 14: 1002777, 2022.
Article de En | MEDLINE | ID: mdl-36533174

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Front Aging Neurosci Année: 2022 Type de document: Article Pays d'affiliation: République d'Afrique du Sud Pays de publication: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Front Aging Neurosci Année: 2022 Type de document: Article Pays d'affiliation: République d'Afrique du Sud Pays de publication: Suisse